Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Net Cash Flow: 2023-2024

Historic Net Cash Flow for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $300.3 million.

  • Upstream Bio's Net Cash Flow rose 288.15% to $26.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.2 million, marking a year-over-year increase of 376.64%. This contributed to the annual value of $300.3 million for FY2024, which is 3318.96% up from last year.
  • According to the latest figures from FY2024, Upstream Bio's Net Cash Flow is $300.3 million, which was up 3,318.96% from $8.8 million recorded in FY2023.
  • Over the past 5 years, Upstream Bio's Net Cash Flow peaked at $300.3 million during FY2024, and registered a low of $8.8 million during FY2023.
  • Moreover, its 2-year median value for Net Cash Flow was $154.5 million (2023), whereas its average is $154.5 million.
  • Data for Upstream Bio's Net Cash Flow shows a peak YoY surged of 3,318.96% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Upstream Bio's Net Cash Flow stood at $8.8 million in 2023, then soared by 3,318.96% to $300.3 million in 2024.